drugset / Trial / NCT02500316
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
NaSingle-groupOpen-labelTreatment
Summary
Protocol CP-4-004-OLE (Open Label Extension) is designed as a long-term, open-label extension using single patient use, multi-dose, disposable pre-filled pen.
Timeline
- Start
- 2014-02
- Primary completion
- 2023-11
- Completion
- 2023-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatrogon | Protein / enzyme biologic | 20 mg/ml | Other |
| Subject | Somatrogon | Protein / enzyme biologic | 50 mg/ml | Other |